BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 31209670)

  • 1. Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database.
    Mao R; Zhao H; Li K; Luo S; Turner M; Cai JQ; Blazer D
    Ann Surg Oncol; 2019 Sep; 26(9):2722-2729. PubMed ID: 31209670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal Cut-Off Values of the Positive Lymph Node Ratio and the Number of Removed Nodes for Patients Receiving Resection of Bronchopulmonary Carcinoids: A Propensity Score-Weighted Analysis of the SEER Database.
    Chen Q; Li M; Wang P; Chen J; Zhao H; Zhao J
    Front Oncol; 2021; 11():696732. PubMed ID: 34367980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary tumor resection and lymph node dissection improve survival in
    Wu C; Zhang X; Wang T; Zhou H; Guo C; Chen Y; Zhao D
    Transl Cancer Res; 2020 May; 9(5):3312-3323. PubMed ID: 35117698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
    Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
    BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes.
    Mazzone E; Preisser F; Nazzani S; Tian Z; Bandini M; Gandaglia G; Fossati N; Montorsi F; Graefen M; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    Eur Urol Oncol; 2019 Sep; 2(5):541-548. PubMed ID: 31411992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States.
    Gratian L; Pura J; Dinan M; Roman S; Reed S; Sosa JA
    Ann Surg Oncol; 2014 Oct; 21(11):3515-21. PubMed ID: 24841347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.
    Zhu J; Liu C; Li H; Ren H; Cai Y; Lan T; Wu H
    Cancer Med; 2023 Apr; 12(7):8184-8198. PubMed ID: 36645113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: A multi-institutional analysis.
    Wu L; Sahara K; Tsilimigras DI; Maithel SK; Poultsides GA; Rocha FG; Weber SM; Fields RC; Idrees K; Cho CS; Shen F; Pawlik TM;
    J Surg Oncol; 2019 Dec; 120(7):1080-1086. PubMed ID: 31468550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of adequate pelvic lymph node dissection on overall survival after radical cystectomy: A stratified analysis by clinical stage and receipt of neoadjuvant chemotherapy.
    von Landenberg N; Speed JM; Cole AP; Seisen T; Lipsitz SR; Gild P; Menon M; Kibel AS; Roghmann F; Noldus J; Sun M; Trinh QD
    Urol Oncol; 2018 Feb; 36(2):78.e13-78.e19. PubMed ID: 29169845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of lymph node dissection in intrahepatic cholangiocarcinoma: a multicenter retrospective study.
    Hu H; Xu G; Du S; Luo Z; Zhao H; Cai J
    BMC Surg; 2021 Oct; 21(1):359. PubMed ID: 34627199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends and outcomes of lymphadenectomy for nonmetastatic renal cell carcinoma: A propensity score-weighted analysis of the National Cancer Database.
    Farber NJ; Rivera-Núñez Z; Kim S; Shinder B; Radadia K; Sterling J; Modi PK; Goyal S; Parikh R; Mayer TM; Weiss RE; Kim IY; Elsamra SE; Jang TL; Singer EA
    Urol Oncol; 2019 Jan; 37(1):26-32. PubMed ID: 30446458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management.
    Lopez-Aguiar AG; Ethun CG; Zaidi MY; Rocha FG; Poultsides GA; Dillhoff M; Fields RC; Idrees K; Cho CS; Abbott DE; Cardona K; Maithel SK
    Surgery; 2019 Jul; 166(1):15-21. PubMed ID: 31072670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of L4 lymph node dissection on long-term survival in left-side operable non-small-cell lung cancer: a propensity score matching study.
    Yang MZ; Hou X; Li JB; Cai JS; Yang J; Li S; Long H; Fu JH; Zhang LJ; Lin P; Rong TH; Yang HX
    Eur J Cardiothorac Surg; 2020 Jun; 57(6):1181-1188. PubMed ID: 32016340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More lymph node dissection improves survival in patients with newly diagnosed lymph node-positive penile cancer.
    Mao W; Huang X; Kong M; Fan J; Geng J
    Int Urol Nephrol; 2019 Apr; 51(4):641-654. PubMed ID: 30758771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of primary tumor resection and lymph node dissection in stage IV colorectal cancer with unresectable metastasis: a propensity score analysis in a multicenter retrospective study.
    Ishihara S; Hayama T; Yamada H; Nozawa K; Matsuda K; Miyata H; Yoneyama S; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kanazawa T; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Hashiguchi Y; Sugihara K; Watanabe T
    Ann Surg Oncol; 2014 Sep; 21(9):2949-55. PubMed ID: 24763981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer.
    Amit M; Tam S; Boonsripitayanon M; Cabanillas ME; Busaidy NL; Grubbs EG; Lai SY; Gross ND; Sturgis EM; Zafereo ME
    JAMA Otolaryngol Head Neck Surg; 2018 Feb; 144(2):108-114. PubMed ID: 29192312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection.
    Faiena I; Salmasi A; Lenis AT; Donin NM; Johnson DC; Bachour K; Drakaki A; Belldegrun AS; Pantuck AJ; Chamie K
    Urol Oncol; 2018 Feb; 36(2):79.e19-79.e26. PubMed ID: 29103965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data Analysis.
    Zhang XF; Xue F; Dong DH; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Lv Y; Maithel SK; Pawlik TM
    Ann Surg; 2021 Jul; 274(1):e28-e35. PubMed ID: 31356277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value and Clinical Predictors of Lymph Node Metastases in Pancreatic Neuroendocrine Tumors.
    Zhang Z; Liu M; Ji S; Luo G; Xu W; Liu W; Hu Q; Sun Q; Ye Z; Qin Y; Fan G; Yu X; Xu X
    Pancreas; 2020 Mar; 49(3):381-386. PubMed ID: 32132507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emulating Target Clinical Trials of Radical Nephrectomy With or Without Lymph Node Dissection for Renal Cell Carcinoma.
    Bacic J; Liu T; Thompson RH; Boorjian SA; Leibovich BC; Golijanin D; Gershman B
    Urology; 2020 Jun; 140():98-106. PubMed ID: 32142726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.